Biotech Values

[iwfal]

On the other hand, Durysta doesn’t seems to be fully absorbed, see this discussion, so that might explain why repeated dosing is problematic:

FWIW - there seems to be a general assumption that the problem is the physical interactions of the implants with the eye compartment. But this seems iffy to me. Maybe true, maybe not. Not enough attention is paid to the fact that the doses used result in astronomical concentrations in that compartment of the eye.